Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | $6,130.0M | $7,175.0M | $11.9B | $8,195.0M | $8,400.0M | $9,794.0M | $9,113.0M | $9,505.0M | $9,175.0M | $10.2B | $17.8B | $6,712.0M | $7,703.0M | $12.6B | $7,147.0M | $8,072.0M | $24.0B | $6,955.0M | $14.9B | $11.9B |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Novartis AG's last 12-month Net Income is $11.9B, based on the financial report for Dec 31, 2024 (Q4 2024).
Over the last year, Novartis AG's Net Income growth was (19.6%). The average annual Net Income growth rates for Novartis AG have been 9.9% over the past three years, 0.4% over the past five years.
Over the last year, Novartis AG's Net Income growth was (19.6%), which is lower than industry growth of (0.2%). It indicates that Novartis AG's Net Income growth is Bad.